The Economic Impact of the Lack of Patient Engagement

Clinical Trials

$17B Avoidable Expense
  • Current solutions are high-friction, error prone, and delayed

Pharma

$188B Potential Revenues
  • Patients don’t take drugs, resulting in lost Drug revenues

Payers

$100B Avoidable Cost
  • Patients stay sick resulting in more treatment costs

“..If Patient engagement were a drug, it would be a blockbuster drug of the century..” - Deloitte.

Our Solution

Picture3

Using miniaturized sensors embedded / sticked on Drug packaging and Machine Learning on real-time patient behavior data, our solution enables passive monitoring of patient’s medicine intake events, provides interventions to improve patient engagement and enables sharing of these crucial data / analytics. Overall the system is a closed loop solution, to monitor and improve patient engagement.

Customer Use Cases

Clinical Trials

  1. Competitive edge
  2. Accurate, real-time data capture
  3. Bottom-line cost reduction

Pharma Companies

  1. Enables value based pay
  2. Top-line revenues
  3. Gain insights about patient medicine taking behavioral data

Payers & Insurance

  1. Decreases Cost of providing healthcare
  2. Enables Value based Pay
  3. Accurate and convenient capture of Patient drug taking bevahior

Partners & Awards

We provide innovative Machine Learning enabled solutions to our Customers to address their Patient Engagement needs

WE ARE HERE TO HELP​

Our is solution available today for Real-Time Patient Monitoring and Patient Engagement

The Annual cost of Patient’s non-adherence to medicine in US
$ 0 B

Revenue Lost by Pharma

$ 0 B

Avoidable Cost for CROs

$ 0 B

Avoidable Expenses for Payers

Pacific Life Technologies (DBO Hlthally), Sunnyvale, California